Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

As tumor tissues express high levels of folate receptors, folate or folic acid have been widely used as a part of selective targeting of various anticancer agents, to specifically combine with folate ...